“…Despite these challenges, naturally-derived small molecules, specifically polyphenols, are commonly investigated for preventing Aβ40/IAPP self-aggregation ( Porat et al, 2006 ; Dhouafli et al, 2018 ). In this research, we selected the polyphenols, Caffeic acid ( Cheng et al, 2011 ; Chang et al, 2019 ), Myricetin ( Ono et al, 2003 , 2012 ; Shimmyo et al, 2008 ; DeToma et al, 2011 ; Zelus et al, 2012 ; Gargari et al, 2018 ; Dubey et al, 2021 ), Rosmarinic acid ( Ono et al, 2012 ; Sun et al, 2019 ), Curcumin ( Ono et al, 2004 ; Daval et al, 2010 ; Nedumpully-Govindan et al, 2016 ; Thapa et al, 2016 ), EGCG ( Bastianetto et al, 2006 ; Ehrnhoefer et al, 2008 ; Bieschke et al, 2010 ; Meng et al, 2010 ; Liu et al, 2011 ; Cao and Raleigh, 2012 ; Suzuki et al, 2012 ; Cheng et al, 2013 ; Hyung et al, 2013 ; Zhang et al, 2013 ; Wang Q. et al, 2014 ; Xu et al, 2016 ) and Silibinin ( Yin et al, 2011 ; Cheng B et al, 2012 ; Sciacca et al, 2017 ), as candidate inhibitors of Aβ40 and IAPP self-aggregation based on their known anti-aggregation activities in literature. Figure 5A demonstrates the chemical structures of the polyphenolic candidate inhibitors.…”